Alan B. Lancz & Associates, Inc. Abbott Laboratories Transaction History

Alan B. Lancz & Associates, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $117,874 - $138,284	1,240 New	1,240 $136,000
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $54,301 - $65,632	-532 Reduced 30.02%	1,240 $135,000
Q4 2021 Apr 13, 2022	SELL	$115.53 - $141.46 $4.16 Million - $5.09 Million	-36,000 Reduced 95.31%	1,772 $249,000
Q4 2021 Feb 09, 2022	BUY	$115.53 - $141.46 $4.36 Million - $5.34 Million	37,772 New	37,772 $5.32 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Alan B. Lancz & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Alan B. Lancz & Associates, Inc. with notifications on news.